XML 28 R40.htm IDEA: XBRL DOCUMENT v2.4.0.6
Stockholders' Equity (Details 3) (USD $)
3 Months Ended 3 Months Ended
Mar. 31, 2013
item
Mar. 31, 2012
Mar. 31, 2013
Stock Options
Mar. 31, 2013
Stock Options
Minimum
Mar. 31, 2013
Stock Options
Maximum
May 03, 2013
Stock Options
Employee plan, the Executive plan, the 2005 plan or the 1999 plan
Mar. 31, 2013
Restricted Stock Units
Mar. 31, 2013
Restricted Stock Units
Minimum
Mar. 31, 2013
Restricted Stock Units
Maximum
Stock option                  
Number of stock-based compensation plans 5                
Vesting period     4 years         2 years 4 years
Award expiration from grant date     10 years            
Number of Shares                  
Outstanding at beginning of the year (in shares)     6,854,369            
Granted (in shares)     391,275            
Forfeited (in shares)     (31,671)            
Exercised (in shares)     (100,671)            
Outstanding at end of the period (in shares)     7,113,302            
Exercisable at end of the period (in shares)     3,849,690            
Available for future grants at the end of the period (in shares)     173,682     0      
Weighted Average Exercise Price                  
Outstanding at beginning of the year (in dollars per share)     $ 7.92            
Granted (in dollars per share)     $ 14.29            
Forfeited (in dollars per share)     $ 10.48            
Exercised (in dollars per share)     $ 2.97 $ 0.25 $ 12.56        
Outstanding at end of the period (in dollars per share)     $ 8.33            
Exercisable at end of the period (in dollars per share)     $ 5.06            
Weighted Average Contractual Life (years)                  
Outstanding at end of the period     7 years 6 months            
Exercisable at end of the period     6 years 4 months 24 days            
Intrinsic Value                  
Outstanding     $ 37,296,821            
Vested     29,926,026            
Exercised     1,133,058            
Proceeds from stock option exercises                  
Proceeds from stock option exercises     300,000            
Aggregate fair value of grant             7,700,000    
Stock-based compensation expenses 3,099,000 1,624,000         700,000    
Total unrecognized compensation cost, net of estimated forfeitures, related to unvested units             $ 10,100,000    
Number of Shares                  
Outstanding at beginning of the year (in shares)             221,314    
Granted (in shares)             519,034    
Vested (in shares)             (37,957)    
Outstanding at end of the period (in shares)             702,391    
Weighted Average Fair Value                  
Outstanding at beginning of the year (in dollars per share)             $ 17.27    
Granted (in dollars per share)             $ 14.93    
Vested (in dollars per share)             $ 16.29    
Outstanding at end of the period (in dollars per share)             $ 15.59